SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-011637
Filing Date
2019-12-20
Accepted
2019-12-20 07:03:50
Documents
15
Period of Report
2019-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20191219x8kb2b8746.htm   iXBRL 8-K 36054
2 EX-10.1 ex-10d1.htm EX-10.1 194966
3 EX-10.2 ex-10d2.htm EX-10.2 57211
4 EX-10.3 ex-10d3.htm EX-10.3 48780
  Complete submission text file 0001558370-19-011637.txt   505431

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20191219.xsd EX-101.SCH 3041
6 EX-101.LAB imgn-20191219_lab.xml EX-101.LAB 16757
7 EX-101.PRE imgn-20191219_pre.xml EX-101.PRE 9904
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20191219x8kb2b8746_htm.xml XML 4692
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 191297632
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences